Progress towards elimination goals for viral hepatitis.
Andrea L CoxManal H El-SayedJia-Horng KaoJeffrey Victor LazarusMaud LemoineAnna S LokFabien ZoulimPublished in: Nature reviews. Gastroenterology & hepatology (2020)
The global burden of viral hepatitis is substantial; in terms of mortality, hepatitis B virus and hepatitis C virus infections are on a par with HIV, malaria and tuberculosis, among the top four global infectious diseases. In 2016, the 194 Member States of the World Health Organization committed to eliminating viral hepatitis as a public health threat by 2030, with a particular focus on hepatitis B virus and hepatitis C virus infection. With only 10 years to go until the 2030 deadline is reached, and although much progress has been made towards elimination, there are still some important gaps in terms of policy and progress. In this Viewpoint, we asked a selection of scientists and clinicians working in the viral hepatitis field for their opinions on whether elimination of viral hepatitis by 2030 is feasible, what the key areas of progress are and what the focus for the next 10 years and beyond should be for viral hepatitis elimination.
Keyphrases
- hepatitis b virus
- sars cov
- public health
- hepatitis c virus
- infectious diseases
- liver failure
- human immunodeficiency virus
- mycobacterium tuberculosis
- hepatitis c virus infection
- antiretroviral therapy
- cardiovascular disease
- hiv aids
- risk factors
- coronary artery disease
- hiv positive
- pulmonary tuberculosis
- hiv testing